The FDAs Pharmacy Compounding Advisory Committee (PCAC) is scheduled to formally review BPC-157 for inclusion on the 503A Bulks List on July 23, 2026
This contributes to a more stable secondary structure under laboratory conditions
My first instinct was that, regardless of claimed ignorance regarding WADAs list, Mike should have done his due diligence and if he wanted to continue competing, gone ahead with the surgery
further evidence that this is a benign disorder
By targeting melatonin synthesis and circadian gene expression, Epitalon could act as a molecular metronome, realigning internal timekeeping mechanisms that tend to falter with age
The picture is consistent: the adverse events are overwhelmingly gastrointestinal, they track with dose, and they cluster during escalation